Arvida Group Ltd
NZX:ARV
P/S
Price to Sales
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
Market Cap | P/S | ||||
---|---|---|---|---|---|
NZ |
Arvida Group Ltd
NZX:ARV
|
698.9m NZD | 3 | ||
US |
HCA Healthcare Inc
NYSE:HCA
|
85.4B USD | 1.3 | ||
SA |
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
101.6B SAR | 10.4 | ||
CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
120.8B CNY | 5.9 | |
ZA |
N
|
Netcare Ltd
JSE:NTC
|
15.6B Zac | 0 | |
ZA |
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
15.5B Zac | 0 | |
BR |
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
70.1B BRL | 1.5 | ||
TH |
B
|
Bangkok Dusit Medical Services PCL
SET:BDMS
|
452.9B THB | 4.5 | |
US |
Tenet Healthcare Corp
NYSE:THC
|
12.5B USD | 0.6 | ||
US |
Universal Health Services Inc
NYSE:UHS
|
11.9B USD | 0.8 | ||
MY |
I
|
IHH Healthcare Bhd
KLSE:IHH
|
55.6B MYR | 2.7 |
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.